Human S100B(S100 Calcium Binding Protein B) ELISA Kit
中文名称:人S100钙结合蛋白B(S100B)酶联免疫吸附测定试剂盒

Price:
- 反应性: Human
- 检测范围: 31.25-2000 pg/mL
- 灵敏度: 18.75 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人S100B抗体包被于酶标板上,实验时样品(或标准品)中的人S100B会与包被抗体结合。后依次加入生物素化的抗人S100B抗体和辣根过氧化物酶标记的亲和素,抗人S100B抗体与结合在包被抗体上的人S100B结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,S100B浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中S100B的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Human |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 31.25-2000 pg/mL |
灵敏度 | 18.75 pg/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的人S100B,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
Effect of Astragalus Membranaceus on Neurological Function in Acute aneurysmal subarachnoid hemorrhage patients with high inflammation: A Preliminary Randomized, Double-Blind, Placebo-Controlled Clinical Trial
IF: 3.300Journal: Journal of Traditional and Complementary Medicine (2024)Reactivity:HumanSample Type:serum,cerebrospinal fluid (CSF) -
Unique content of breastmilk: neurotrophic growth factors in breastmilk at 2 years and beyond
IF: 3.000Journal: EUROPEAN JOURNAL OF PEDIATRICS (2024)Reactivity:HumanSample Type:breast milk sample -
The effects of hyperbaric oxygen therapy on neuroprotection and recovery after brain resuscitation
IF: 1.700Journal: INTERNATIONAL JOURNAL OF NEUROSCIENCE (2024)Reactivity:HumanSample Type:venous blood -
The elastin-derived peptide (VGVAPG) activates autophagy in neuroblastoma (SH-SY5Y) cells via peroxisome proliferator-activated receptor gamma (PPARγ)
IF: 3.500 -
Prediction of Normal Tissue Complication Probability (NTCP) After Radiation Therapy Using Imaging and Molecular Biomarkers and Multivariate Modelling
IF: 3.100Journal: JOURNAL OF MOLECULAR NEUROSCIENCE (2023)Reactivity:HumanSample Type:serum -
Effect of pre-infusion of hypertonic saline on postoperative delirium in geriatric patients undergoing shoulder arthroscopy: a randomized controlled trial
IF: 2.200 -
Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms
IF: 4.553Journal: JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)PMID:35752131Reactivity:HumanSample Type:serum -
Examination of Cognitive Function, Neurotrophin Concentrations, and both Brain and Systemic Inflammatory Markers Following a Simulated Game of American Football
IF: 4.415Journal: JOURNAL OF STRENGTH AND CONDITIONING RESEARCH (2022)Reactivity:HumanSample Type:serum -
Neurofilament light chain and S100B serum levels are associated with disease severity and outcome in patients with aneurysmal subarachnoid hemorrhage
IF: 4.086 -
Can the Prognosis of COVID-19 Disease Be Determined by Fecal Markers and Cytokines?
IF: 3.657Journal: JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2022)PMID:36179036Reactivity:HumanSample Type:fecal